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Abstract. 
 
In cellular transformation, activated forms of
the small GTPases Ras and RhoA can cooperate to drive
cells through the G1 phase of the cell cycle. Here, we show
that a similar but substrate-regulated mechanism is in-
volved in the anchorage-dependent proliferation of un-
transformed NIH-3T3 cells. Among several extracellular
matrix components tested, only ﬁbronectin supported
growth factor–induced, E2F-dependent S phase entry. Al-
though all substrates supported the mitogen-activated
protein kinase (MAPK) response to growth factors,
RhoA activity was speciﬁcally enhanced on ﬁbronectin.
Moreover, induction of cyclin D1 and suppression of
 
p21
 
Cip/Waf
 
 occurred speciﬁcally, in a Rho-dependent fash-
ion, in cells attached to ﬁbronectin. This ability of ﬁbro-
nectin to stimulate both Ras/MAPK- and RhoA-depen-
dent signaling can explain its potent cooperation with
growth factors in the stimulation of cell cycle progression.
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Introduction
 
In tissues, cells are surrounded by a network of various
proteins and polysaccharides that constitutes the extracel-
 
lular matrix (ECM).
 
1
 
 ECM components dramatically af-
fect proliferation and differentiation of cells in culture
(Roskelley et al., 1995; Assoian, 1997), and the ability of
cells to grow relatively independently from cell–matrix in-
teractions is a key event in malignant transformation
(Freedman and Shin, 1974). Many cell–matrix interactions
are mediated by the integrin family of cell adhesion recep-
tors (Hynes, 1992; Sonnenberg, 1993). Integrin-mediated
adhesion triggers cell spreading, rearrangement of the ac-
tin cytoskeleton, and organization of integrins and associ-
ated proteins into cell–matrix adhesions (Burridge and
Chrzanowska-Wodnicka, 1996). These processes are regu-
lated by small GTPases of the Rho family, and they ulti-
mately affect multiple signaling pathways (Howe et al.,
1998; Giancotti and Ruoslahti, 1999; Yamada and Danen,
2000).
Control of growth by cell anchorage takes place in the
G1 phase of the cell cycle (Assoian, 1997). Progression
through G1 occurs via sequential activation of cyclin
D–cdk4/6 and cyclin E–cdk2 kinase complexes, phosphor-
ylation of the Rb family of pocket proteins resulting in the
release of the E2F transcription factor, followed by the
transcription of several genes whose products are required
for the initiation of S phase (Beijersbergen and Bernards,
1996). Cell adhesion has been reported to control the tran-
scription and translation of cyclin D1 and the levels and/or
distribution of the p21
 
Cip/Waf
 
 and p27
 
Kip1
 
 inhibitors of the
cyclin E–cdk2 complex. As a consequence, phosphoryla-
tion of the pocket proteins, availability of free E2F, and in-
duction of cyclin A early in S phase are anchorage depen-
dent (Schulze et al., 1995; Zhu et al., 1996; Bohmer et al.,
1996; Carstens et al., 1996; Fang et al., 1996; Kang and
Krauss, 1996; Kramer et al., 1996; Bottazzi et al., 1999).
Currently, the mechanisms by which cell adhesion mod-
ulates growth factor signaling cascades are incompletely
understood. Mitogen-activated protein kinase (MAPK)
and Rho family members are both essential for cell cycle
progression through G1 (Pages et al., 1993; Olson et al.,
1995), and integrins can collaborate with growth factors to
activate both pathways (Renshaw et al., 1997; Price et al.,
1998; Aplin and Juliano, 1999; Ren et al., 1999). In the
present study we find that cell spreading in general, which
acts in synergy with growth factor signaling to activate ex-
tracellular signal–regulated kinase (ERK)-type MAPK, is
not sufficient to promote cell cycle progression in NIH-
3T3 cells stimulated with growth factors in the absence of
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serum. Adhesion to fibronectin specifically stimulates
RhoA activity and supports cyclin D1 induction and
p21
 
Cip/Waf
 
 suppression in a RhoA-dependent fashion, a
mechanism that we find to be instrumental in anchorage-
dependent G1 cell cycle progression.
 
Materials and Methods
 
Antibodies and Adhesive Ligands
 
Polyclonal antibody C-15 (Santa Cruz Biotechnology, Inc.) and mono-
clonal antibody G3-245 (BD PharMingen) were used for immunoprecipi-
tation and Western blotting of Rb. Antibodies to cyclin D1 and p21
 
Cip/Waf
 
were from Upstate Biotechnology. Paxillin, ERK1, and ERK2 mono-
clonal antibodies used for immunofluorescence and Western blotting
were from Transduction Laboratories. Monoclonal antibodies against
RhoA (Santa Cruz Biotechnology, Inc.) and Rac1 (Upstate Biotechnol-
ogy) were used for Western blotting, as were monoclonal antibody 9E10
against the Myc epitope (BAbCo) and a monoclonal antibody against the
phosphorylated Thr202/Tyr204 ERK activation epitope (New England
Biolabs, Inc.). Fibronectin was purified from human plasma as described
previously (Miekka et al., 1982), and its purity was confirmed by SDS-
PAGE (not shown). Laminin 1 was purchased from Collaborative Bio-
medical Products, collagen type 1 was from Collagen Corporation, and
poly-
 
L
 
-lysine was from Sigma-Aldrich.
 
Plasmids and Retroviral Expression Constructs
 
Luciferase reporter constructs for cyclin A (cyclin A gene promoter re-
gion from 
 
2
 
7300 to 
 
1
 
11 relative to the major transcription start site)
(Schulze et al., 1995), cyclin A with a mutated E2F-binding site (harboring
a mutated E2F site at 
 
2
 
37 to 
 
2
 
33) (Schulze et al., 1995), cyclin D1 (pro-
moter region from 
 
2
 
973 to 
 
1
 
139), and for p21
 
Cip/Waf
 
 (2.4-kb p21 promoter
region) were gifts from Berthold Henglein (Institut Curie, Paris, France).
Rb(NPC
 
2
 
) cDNA encoding a pRb mutant lacking 14 phosphorylation
sites, rendering it insensitive to inactivation by G1 cyclin–cdk complexes
(Chew et al., 1998), was a gift from Sibylle Mittnacht (Institute for Cancer
Research, London, UK). An expression plasmid for 
 
Clostridium botuli-
num
 
 C3 toxin pCEF/C3 was a gift from J. Silvio Gutkind (National Insti-
tutes of Health). The dominant inhibitory MAPK kinase (MEK) plasmid
pMCL
 
!
 
HA/MEK K97M (Mansour et al., 1994) was provided by Natalie
Ahn (University of Colorado, Boulder, CO). The mouse cyclin D1 and
p21
 
Cip/Waf
 
 probes were gifts from Charles Sherr (St. Jude Children’s Re-
search Hospital, Memphis, TN), Wade Harper (Baylor College of Medi-
cine, Houston, TX), and Konrad Huppi (National Institutes of Health).
The puromycin resistance plasmid pHA262pur was provided by Hein te
Riele (The Netherlands Cancer Institute, Amsterdam). Supernatants
from the Phoenix packaging cell line transfected with Myc epitope–tagged
N19RhoA or N17Rac1 (Leeuwen et al., 1997) were a gift from John Col-
lard (The Netherlands Cancer Institute, Amsterdam).
 
Cell Culture, cDNA Transfections, and
Retroviral Transductions
 
NIH-3T3 cells obtained from the American Type Culture Collection were
maintained in DME supplemented with 10% calf serum, penicillin, and
streptomycin. All luciferase reporter lines were generated by cotransfec-
tion of the reporter constructs (6 
 
m
 
g each) with empty pcDNA vector (3
 
m
 
g) using Lipofectamine (Life Technologies). Stable transfectants were se-
lected with G418 (0.8 mg/ml; Life Technologies) for 2 wk, and single-cell
clones were isolated by limiting dilution. For each reporter, three indepen-
dent clones were used for initial characterization of the patterns of sup-
pression and activation by serum starvation and stimulation with growth
factors. One representative clone was used for further experiments. Tran-
sient transfections with pcDNA/Rb(NPC
 
2
 
) and pCEF/C3 were done by
electroporation (170 V, 960 
 
m
 
Fd; 20 
 
m
 
g of each of these plasmids) together
with 10 
 
m
 
g pHA262pur, followed by selection in media containing puromy-
cin (1 
 
m
 
g/ml; Sigma-Aldrich) for 3 d. Retroviral infections were performed
by culturing 10
 
5
 
 cells for 8 h with 1 ml cell-free Phoenix supernatant in the
presence of 10 
 
m
 
g/ml DOTAP (Boehringer). Cells were then maintained
overnight in fresh medium and subsequently selected in the presence of
zeocin (0.2 mg/ml; Invitrogen) for 10 d. For transient transfections as well
as retroviral infections, selected cells were maintained in the absence of the
selection drug for 2 d before they were used in experiments.
 
Serum Starvation, Replating, and Growth
Factor Stimulation
 
For synchronization in G0, subconfluent NIH-3T3 cultures were incu-
bated for 24 h in DME without serum (see Fig. 1 for a schematic represen-
tation of the experimental procedure). Cells were then detached with
0.05% trypsin-EDTA and collected in DME containing 2% BSA and 0.5
mg/ml soybean trypsin inhibitor (Sigma-Aldrich), washed in DME, and fi-
nally collected in DME containing 0.2% BSA and counted. For suspen-
sion cultures, cells were replated on wells that had been coated for 1 h at
room temperature with 1% agar in PBS and subsequently been incubated
overnight in DME. For adherent cultures, cells were replated on wells that
had been precoated overnight at 4
 
8
 
C with 10 
 
m
 
g/ml fibronectin, 20 
 
m
 
g/ml
laminin, 20 
 
m
 
g/ml collagen or 100 
 
m
 
g/ml poly-
 
L
 
-lysine and subsequently
been blocked with 2% heat-denatured BSA for 2 h at 37
 
8
 
C. After 16 h in-
cubation on the various substrates, growth factors were added to a final
concentration of 15 ng/ml bFGF (a gift from Gera Neufeld, Technion-
Israel Institute of Technology, Haifa, Israel), 10 ng/ml EGF (Sigma-
Aldrich), 6.25 
 
m
 
g/ml insulin, 6.25 
 
m
 
g/ml transferrin, 6.25 ng/ml selenous
acid, 5.35 
 
m
 
g/ml linoleic acid (ITS1; Collaborative Biomedical Products),
and 1 
 
m
 
g/ml heparin (Sigma-Aldrich).
 
Immunofluorescence Microscopy and Flow Cytometry
 
Serum-starved cells were plated in DME containing 0.2% BSA on cover-
slips precoated with substrates as described above. For detection of inte-
grins, paxillin, and actin, the cells were fixed in 2% paraformaldehyde for
15 min and permeabilized in 0.2% Triton X-100 for 5 min. For detection
of MAPK, cells were fixed in 70% methanol/30% acetone for 10 min on
dry ice. For immunofluorescence staining, the coverslips were then
blocked with 10% heat-inactivated calf serum for 1 h and incubated with
primary antibodies (5 
 
m
 
g/ml) for 1 h at room temperature. After washing
with PBS, cells were incubated with Texas red–conjugated secondary anti-
bodies (Jackson ImmunoResearch Laboratories) or Oregon green–conju-
gated phalloidin (Molecular Probes) for 1 h at room temperature. Prepa-
rations were then washed in PBS, mounted in Vectashield (Vector
Laboratories), and analyzed with a confocal Leica TCS NT microscope.
 
Luciferase Assays
 
Serum-starved cells were collected, plated at a subconfluent density of 10
 
4
 
cells per well in precoated 48-well plates, and stimulated with growth fac-
tors as described above. At the indicated time points, medium was aspi-
rated from adherent cultures and suspended cells were collected with a
microcentrifuge. Cells were then lysed in 50 
 
m
 
l Passive Lysis Buffer
 
®
 
(Promega) and assayed for luciferase activity (Luciferase Assay System;
Promega). Results are presented as the mean 
 
6 
 
SD of data from two or
more independent experiments, each of which was done in triplicate.
 
Immunoprecipitation and Western Blotting
 
Serum-starved cells were collected, plated at a subconfluent density of 10
 
5
 
cells per well in precoated 6-well plates, and stimulated with growth factors
as described above. For analysis of total cell lysates, cells were lysed at the
indicated time points in boiling Laemmli sample buffer. For immunopre-
cipitation, cells were lysed in 750 
 
m
 
l modified RIPA buffer (50 mM Tris-
HCl, pH 7.5, 150 mM sodium chloride, 1% Triton X-100, 2 mM EDTA, 1%
sodium deoxycholate, 0.1% SDS, 10 mM sodium fluoride, 10 mM 
 
b
 
-glyc-
erophosphate, 1 mM sodium orthovanadate, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml
aprotinin, and 1 mM PMSF) and lysates were clarified by centrifugation at
14,000 
 
g
 
 for 20 min at 4
 
8
 
C. Clarified lysates were then incubated overnight
at 4
 
8
 
C with 2 
 
m
 
g/ml of the antibody. Immune complexes were collected
with 10 
 
m
 
l GammaBind (Amersham Pharmacia Biotech) for 2 h at 4
 
8
 
C,
washed three times with lysis buffer, and solubilized in Laemmli sample
buffer. Total cell lysates or immunoprecipitates were resolved by SDS-
PAGE, transferred to polyvinylidene difluoride membranes (Millipore),
and analyzed by Western blotting followed by enhanced chemilumines-
cence using the SuperSignal system (Pierce Chemical Co.).
 
Biochemical Assays for Activity of RhoA and Rac1
 
Activity assays were based on the fact that GTPase effector proteins bind
their specific partner GTPases only when they are in the GTP-bound (ac-
tive) form, and the assays were performed essentially as described previ-
ously (Sander et al., 1998; Ren et al., 1999). Serum-starved cells were col-
lected, plated at a subconfluent density of 2 
 
3 
 
10
 
6
 
 cells per precoated
15-cm dish, and stimulated with growth factors as described above. For 
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each indicated time point, the cells in two dishes were lysed in NP-40 lysis
buffer (50 mM Tris-HCl, pH 7.4, 100 mM sodium chloride, 1% NP-40,
10% glycerol, 2 mM magnesium chloride, 10 mM sodium fluoride, 10 mM
 
b
 
-glycerophosphate, 1 mM sodium orthovanadate, 10 
 
m
 
g/ml leupeptin, 10
 
m
 
g/ml aprotinin, and 1 mM PMSF), and lysates were clarified by centrifu-
gation at 14,000 
 
g
 
 for 20 min at 4
 
8
 
C. A 5% aliquot was removed for deter-
mination of total quantities of the GTPase being analyzed. Clarified ly-
sates were then incubated for 1 h at 4
 
8
 
C with glutathione 
 
S
 
-transferase
(GST) fusion proteins (provided by John Collard, The Netherlands Can-
cer Institute, Amsterdam) that had been precoupled to Sepharose-glu-
tathione beads (Amersham Pharmacia Biotech), and bound complexes
were washed three times in NP-40 lysis buffer. The RhoA activity assay
used a GST fusion protein with the Rho-binding domain of the Rho effec-
tor protein Rhotekin. For the Rac1 activity assay, a GST fusion protein of
the binding domain of the Rac effector protein PAK1b was used. The
samples were analyzed by SDS-PAGE and Western blotting using RhoA
and Rac1 antibodies to detect bound activated GTPases.
 
Northern Blotting
 
Serum-starved cells were collected, plated at a subconfluent density of 10
 
6
 
cells per precoated 10-cm dish, and stimulated with growth factors as de-
scribed above. At the indicated time points, cells were lysed in 1 ml TRI-
zol (Life Technologies) and RNA was isolated according to the manufac-
turer’s protocol. 5 
 
m
 
g RNA of each sample was denatured, mixed with
RNA loading buffer, and resolved on a 1.5% MOPS/formaldehyde/aga-
rose gel in MOPS buffer according to standard procedures (Sambrook et
al., 1989). The RNAs were transferred to a Hybond membrane (Amer-
sham Pharmacia Biotech), hybridized with random-primed cDNA probes
in ExpressHyb mix (CLONTECH Laboratories, Inc.) as described in the
manufacturer’s protocol, washed sequentially with 1
 
3
 
 SSC/0.1% SDS and
0.1
 
3
 
 SSC/0.1% SDS at 55
 
8
 
C, and used for autoradiography.
 
Results
 
Fibronectin Specifically Supports Rb-controlled 
S Phase Entry
 
Serum-starved NIH-3T3 cells were detached and seeded
overnight in the absence of serum or growth factors on agar
(suspended cells), polylysine (cells spread on a nonintegrin
binding substrate), or fibronectin, laminin, or collagen
(cells spread using different integrins on each ECM compo-
nent) (Fig. 1). The cells were well spread on polylysine, fi-
bronectin, and collagen, whereas cells that attached to lami-
nin remained poorly spread (not shown). Growth factors
were added 16 h after plating to avoid any transient signal-
ing activated by trypsinization and replating. Subsequently,
cells were assayed for Rb phosphorylation status or activa-
tion of a cyclin A luciferase reporter construct. Hyperphos-
phorylation of Rb was detected 16 h after growth factor
stimulation only in cells plated on fibronectin (Fig. 2 A).
Similarly, cyclin A promoter activity was strongly induced
after 20 h in cells plated on fibronectin, whereas it re-
mained weak or absent in cells plated on the other sub-
strates (Fig. 2 B). Addition of 10% calf serum to cells
plated on polylysine rescued Rb hyperphosphorylation and
cyclin A induction (Fig. 2, A and B), confirming that the
cells were viable and responsive. Consistent with these
findings, BrdU labeling on coverslips and propidium iodide
staining for FACS
 
®
 
 showed that cells plated on fibronectin
could enter S phase, whereas cells maintained in suspension
or plated on other substrates did not (not shown).
Phosphorylation of Rb family members allows the E2F-
dependent transcription of genes such as cyclin A that are
involved in initiating S phase, although a pathway inde-
pendent of E2F has also been described (Lukas et al.,
1997; Chew et al., 1998). Therefore, we tested whether the
 
inactivation of Rb family members was essential in our ex-
perimental system. A cyclin A reporter construct harbor-
ing a mutated E2F site that was only weakly suppressed by
serum starvation (Schulze et al., 1995, 1996) responded
poorly to growth factor stimulation on each of the sub-
strates tested (Fig. 2 B). This result suggested that the
poor responsiveness of the wild-type cyclin A promoter in
cells plated on substrates other than fibronectin was in-
deed due to repression by E2F in a complex with an Rb
family member. To test this interpretation further, cells
expressing the wild-type cyclin A reporter were transiently
transfected with a cDNA encoding an Rb mutant that can-
not be phosphorylated by cyclin–cdk complexes and there-
fore acts as a dominant inhibitory mutant that is constitu-
tively associated with E2F (Chew et al., 1998). Consistent
with a critical role for E2F-mediated transcriptional regu-
lation of cyclin A in our system, this mutant Rb blocked
the induction of the cyclin A promoter in cells plated on fi-
bronectin (Fig. 2 C).
Thus, fibronectin specifically supports the activation by
growth factors of a signal transduction cascade that leads
to inactivation of Rb and subsequent induction of cyclin A
at entry into S phase.
 
RhoA Activity Is Required for G1 Cell Cycle 
Progression and Is Rescued in Serum-starved Cells
by Replating on Fibronectin
 
The organization of the actin cytoskeleton is thought to
play an important role in the propagation of signal trans-
duction cascades (Chen et al., 1994; Morino et al., 1995;
Zhu and Assoian, 1995). In spite of the prolonged period
of serum starvation (24 h plus an additional 16 h after re-
plating), actin stress fibers spanning the cells were present
in cells plated on fibronectin (Fig. 3 A). In contrast, cells
plated on all of the other substrates showed actin diffusely
distributed in the cytoplasm and in a cortical ring, even
though the cells had spread extensively on polylysine and
collagen. The cells that were spread on laminin (many
were poorly spread) also did not contain stress fibers. Sim-
ilarly, staining for paxillin revealed the presence of cell–
matrix adhesions in cells plated on fibronectin, whereas
the staining pattern was relatively diffuse in cells plated on
each of the other substrates tested (Fig. 3 A).
Because the organization of actin stress fibers and the
formation of cell–matrix adhesions are regulated by RhoA,
Figure 1. Experimental design. After serum starvation for 24 h,
cells were trypsinized and collected in DME containing 2% BSA,
washed, and plated in DME containing 0.2% BSA on various dif-
ferent substrates (point a). Growth factors were added 16 h later
(point b), and the ability of each substrate to support progression
through the G1 phase of the cell cycle was compared. 
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we tested the hypothesis that fibronectin stimulates or res-
cues RhoA activity that is downregulated in serum-starved
cells. Initial support for this notion was provided by the
restoration of growth factor responsiveness in cells plated
on polylysine by serum, which contains the Rho activator
lysophosphatidic acid (LPA) (Ridley and Hall, 1992; Ren
et al., 1999) (Fig. 2, A and B). After serum starvation and
suspension for 2 h, GTP-bound RhoA was barely detect-
able (Fig. 3 B). Plating cells on fibronectin, but not on
polylysine or laminin, for 2 h resulted in a substantial in-
crease in the level of active RhoA. The activation level of
Rac1, another member of the Rho family of small GTPases,
was low in serum-starved cells kept in suspension, and plat-
ing on fibronectin as well as polylysine resulted in elevated
levels of GTP-bound Rac1. Activation of Rac1 was some-
what lower in cells plated on laminin. After overnight in-
cubation, active RhoA was undetectable in cells plated
on polylysine or laminin, whereas a low level remained
present in cells plated on fibronectin (not shown). After
growth factor stimulation, the level of GTP-bound RhoA
was high in cells plated on fibronectin, whereas it remained
low in cells plated on polylysine or laminin (Fig. 3 C). Rac1
activity disappeared after overnight incubation on each of
the substrates (not shown). After stimulation with growth
factors, GTP-bound Rac1 was minimal in cells plated on
laminin whereas GTP-bound Rac1 was precipitated from
cells plated on both fibronectin and polylysine. We ob-
served that cells plated on laminin rounded up and de-
tached after growth factor stimulation (not shown). Thus,
replating on fibronectin specifically stimulated the activity
of RhoA, whereas cell spreading in general appeared to be
associated with Rac1 activity.
 
To test directly whether Rho activity was crucial for the
supportive action of fibronectin, cells were treated with
LPA to activate Rho, or they were transiently transfected
with a cDNA encoding C3 toxin to inhibit Rho (Sekine et
al., 1989; Paterson et al., 1990; Ridley and Hall, 1992; Ren
et al., 1999). Addition of LPA did not induce a response in
suspended cells, but in cells plated on polylysine it sup-
ported weak activation of the cyclin A promoter, which
was blocked in cells transiently transfected with the C3
cDNA (Fig. 3 D). The fact that the effect of LPA was
much weaker than serum indicates the involvement of
other serum components, probably including fibronectin.
Importantly, in cells plated on fibronectin, cyclin A pro-
moter induction was strongly diminished by C3, indicating
a requirement for endogenous Rho activity. As a further
test, we transiently expressed the dominant inhibitory
cDNAs N19RhoA and N17Rac1 using retroviral trans-
duction. In agreement with the results obtained with the
C3 cDNA, N19RhoA inhibited cyclin A promoter activa-
tion in cells plated on fibronectin (Fig. 3 E). Expression of
N17Rac1 was also partially inhibitory, suggesting that ac-
tivity of both GTPases is required.
We conclude that endogenous RhoA activity is specifi-
cally stimulated in serum-starved cells plated on fibronec-
tin and is required for cell cycle progression.
 
Activation of MAPK Is Essential for G1 Progression but 
Does Not Require RhoA-mediated Actin
Cytoskeletal Organization
 
One of the first steps in the progression through G1 is the
induction of cyclin D1 through a MAPK-dependent mech-
anism (Lavoie et al., 1996). Indeed, the induction of a sta-
Figure 2. Fibronectin specifically supports E2F-controlled S phase entry. (A) Serum-
starved cells were plated on agar in suspension (sus), poly-L-lysine (PLL), laminin 1
(LN), collagen 1 (COL), or fibronectin (FN). 16 h after growth factor addition, cells
were lysed and monitored for pRb phosphorylation by immunoprecipitation followed
by Western blotting with Rb antibodies. (B) 20 h after growth factor addition, lu-
ciferase activity was measured in cells stably expressing a wild-type cyclin A luciferase
reporter (black bars) or a cyclin A reporter harboring a mutated E2F site (white bars).
(C) Cells stably expressing a wild-type cyclin A luciferase reporter were transfected
with a puromycin resistance vector combined with an empty pcDNA vector (mock) or
with pcDNA containing a nonphosphorylatable Rb mutant (Rb(NPC2)). After selec-
tion for transfectants in medium containing puromycin, the cells were plated on fi-
bronectin. 20 h after growth factor addition, luciferase activity was measured. 
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bly expressed cyclin D1 luciferase reporter after 4 h of
growth factor stimulation, as well as the more delayed in-
duction of cyclin A (20 h), was inhibited by a dominant in-
hibitory MEK plasmid (Fig. 4 A). Integrin-mediated cell
spreading and growth factors cooperate in the activation
of ERK-type MAPK (Renshaw et al., 1997; Aplin and
Juliano, 1999). Therefore, we tested if the requirement for
Rho-mediated cytoskeletal organization in G1 progression
was at the level of MAPK activation. After trypsinization,
a transient peak of activation of ERK1 and 2 could be de-
tected that was rapidly attenuated in cells maintained in
suspension or plated on polylysine and that decreased at a
slower rate in cells plated on fibronectin in serum-free me-
dium (not shown). After overnight plating in the absence
Figure 3. Fibronectin stimulates RhoA
activity in serum-starved cells. (A) Se-
rum-starved cells were replated overnight
on various substrates as indicated and an-
alyzed for paxillin and actin localization
by immunofluorescence. (B) Serum-
starved cells were plated on the indicated
substrates and lysed after 2 h for bio-
chemical RhoA and Rac1 activity assays.
Levels of bound RhoA or Rac1 (top) or
total levels in a 5% aliquot of each lysate
(bottom) were determined by Western
blotting using RhoA- or Rac1-specific an-
tibodies. (C) Serum-starved cells were
plated overnight on the indicated sub-
strates followed by incubation for 10 min
in the presence of growth factors, then lysed for biochemical RhoA and Rac1 activity assays. In B and C, the percentage of GTP-bound
RhoA and Rac1 was determined according to densitometry of autoradiograms. (D) Cells stably expressing a wild-type cyclin A lu-
ciferase reporter were transfected with a puromycin resistance vector combined with an empty vector (mock) or with a C3 expression
plasmid and selected in medium containing puromycin. Subsequently, the cells were plated in suspension, on polylysine, or on fibronec-
tin, and 20 h after growth factor addition, luciferase activity was measured. (E) Cells stably expressing a wild-type cyclin A luciferase re-
porter were transduced with dominant inhibitory RhoA or Rac1 or control retrovirus and selected in media containing zeocin. Subse-
quently, the cells were plated on fibronectin, and 20 h after growth factor addition luciferase activity was measured. The level of activity
in mock-transduced cells was set at 1. The inset shows Western blot analysis of the Myc-tagged constructs. 
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of growth factors, no activated MAPK was detectable in
cells incubated on any of the substrates tested (Fig. 4 B,
time point 0). After subsequent stimulation with growth
factors, active ERK1 and 2 were detectable on each of the
substrates. In suspended cells, the growth factor–stimu-
lated activity of ERK was rapidly lost, whereas activation
 
was sustained for at least 10 h in cells attached to either
polylysine or fibronectin. Furthermore, nuclear transloca-
tion of ERK in response to growth factors could be ob-
served in cells plated on fibronectin or polylysine (Fig. 4
C) as well as other substrates tested (not shown).
From these findings, we conclude that the activation and
nuclear localization of ERK are essential for G1 progres-
sion and depend on cell adhesion/spreading but not on
RhoA-mediated actin cytoskeletal organization.
 
Fibronectin Stimulates RhoA-dependent Suppression of 
p21
 
Cip/Waf
 
 and Induction of Cyclin D1 Protein
 
It has been reported that the induction of cyclin D1 re-
quires cytoskeletal integrity (Bohmer et al., 1996). To test
if RhoA-dependent actin cytoskeletal organization was re-
quired for cyclin D1 induction, we studied the regulation
of a stably expressed cyclin D1 luciferase reporter, endog-
enous cyclin D1 RNA, and cyclin D1 protein levels in sus-
pended cells and in cells plated on polylysine or fibronec-
tin. In each condition, a transient 7-fold activation of the
luciferase reporter was induced after trypsinization and re-
plating, and a stronger (20-fold) activation occurred after
growth factor stimulation that peaked after 4 h and de-
creased to baseline levels after 
 
z
 
12 h (Fig. 5 A, left). Simi-
larly, in cells plated on polylysine or fibronectin, accumu-
Figure 4. Regulation of ERK-type MAPKs. (A) Cells stably ex-
pressing a luciferase reporter for cyclin A or for cyclin D1 were
transfected with a puromycin resistance vector combined with an
empty vector (mock) or with a dominant inhibitory MEK expres-
sion plasmid and selected in medium containing puromycin. Subse-
quently, the cells were plated on fibronectin and lysed for luciferase
activity assays 4 h (in the case of the cyclin D1 reporter) or 20 h (cy-
clin A reporter) after growth factor addition. (B)  Serum-starved
cells were plated overnight in suspension or on polylysine or fi-
bronectin. They were then stimulated with growth factors and lysed
at the indicated time points for Western blotting with antibodies
against total ERK1 and ERK2 or with a phospho-ERK antibody.
(C) Serum-starved cells were plated overnight on the indicated sub-
strates and fixed for analysis of ERK2 localization by immunofluo-
rescence before (2) or 2.5 h after growth factor stimulation (1).
Figure 5. Regulation of cyclin D1 and p21Cip/Waf RNA. (A) Cells
stably expressing a cyclin D1 (left) or a p21Cip/Waf (right) luciferase
reporter were plated in suspension (sus, filled circles), on poly-
lysine (PLL, open circles), or on fibronectin (FN, filled squares)
(time a) and stimulated with growth factors 16 h later (time b). At
the indicated time points, luciferase activity was measured. (B)
Cells were starved, plated overnight in suspension or on poly-
lysine or fibronectin, and subsequently stimulated with growth
factors. At the indicated time points, cells were lysed for Northern
blotting with probes against mouse cyclin D1 or p21Cip/Waf. 
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lation of endogenous cyclin D1 RNA was detectable 1 h
after growth factor stimulation and became maximal after
4 h (Fig. 5 B). In suspended cells, accumulation of cyclin
D1 RNA was delayed, but it reached similar levels as
those observed in attached cells. In contrast, while expres-
sion of cyclin D1 protein was not detectable in suspended
cells (not shown) and poorly induced in cells plated on
polylysine, it was strongly induced in cells plated on fi-
bronectin (Fig. 6 B). To test whether the stimulation of cy-
clin D1 protein levels by fibronectin depended on the
enhanced Rho activity observed in cells attached to fi-
bronectin, the effect of C3 toxin was evaluated. In cells
expressing the C3 cDNA, the induction of cyclin D1 was
 
suppressed in cells plated on fibronectin, indicating that
endogenous Rho activity was required for this response.
Probing of the same blot for phospho- and total MAPK
levels indicated that this effect of C3 was not due to inhibi-
tion of sustained MAPK activation. The low levels of cy-
clin D1 seen in cells plated on polylysine were not affected
by C3. Parenthetically, we noted that in C3-expressing
cells, cyclin D1 was not always completely absent in the
cells before growth factor stimulation.
RhoA has previously been reported to downmodulate
p21
 
Cip/Waf
 
 levels in cells transformed by oncogenic Ras (Ol-
son et al., 1998). Such a mechanism may also play a role in
the stimulation of cell cycle progression by fibronectin that
we observed. Therefore, we tested whether stimulation of
RhoA activity by fibronectin would result in suppression
of p21
 
Cip/Waf
 
. In cells stably expressing a p21
 
Cip/Waf
 
 lu-
ciferase reporter construct, weak activation was observed
after trypsinization and replating that returned to baseline
levels in cells in suspension or plated on polylysine; how-
ever, levels were further suppressed in cells plated on fi-
bronectin (Fig. 5 A, right). Upon subsequent stimulation
by growth factors, a threefold induction was observed on
all substrates tested that was maximal after 2 h and then
returned to baseline levels over the following 18 h. Simi-
larly, endogenous p21
 
Cip/Waf
 
 RNA became detectable after
30–60 min in suspended as well as attached cells. How-
ever, in suspended cells and in cells plated on polylysine,
p21
 
Cip/Waf
 
 RNA remained present for at least 8 h whereas
in cells plated on fibronectin, it was suppressed at later
time points (Fig. 5 B). We next determined the levels of
p21
 
Cip/Waf
 
 protein under these conditions. No p21
 
Cip/Waf
 
could be detected in serum-starved cells, but its expression
was induced after trypsinization and replating of the cells
(Fig. 6 C, left). This induction of p21
 
Cip/Waf
 
 was rapidly sup-
pressed in adherent cells, whereas protein expression re-
mained high in suspended cells for up to 16 h. Subsequent
stimulation with growth factors induced p21
 
Cip/Waf
 
 expres-
sion in cells plated on polylysine, albeit at low levels,
whereas expression remained undetectable in cells plated
on fibronectin. Furthermore, expression of C3 cDNA neu-
tralized the suppressive effect of fibronectin, demonstrat-
ing that endogenous RhoA activity was required for this
suppressive signal from fibronectin (Fig. 6 C, right). The
moderate levels of p21
 
Cip/Waf
 
 that were induced after
growth factor stimulation of cells plated on polylysine
were not affected by C3 transfection (not shown).
We conclude that activation of RhoA by fibronectin
stimulates the accumulation of cyclin D1 protein, whereas
it suppresses p21
 
Cip/Waf
 
 RNA levels during G1 cell cycle
progression.
 
Discussion
 
Like most untransformed cells, NIH-3T3 fibroblasts only
proliferate in response to growth factors when they are at-
tached to ECM via their integrins. In suspension, they can-
not pass through the restriction point in late G1, but once
the cells have passed this point they no longer require
growth factors or adhesion and are irreversibly committed
to DNA synthesis (Pardee, 1989; Assoian, 1997). Cell adhe-
sion sustains the MAPK response to growth factor stimula-
tion, which in turn is needed for the induction of cyclin D1
(Bohmer et al., 1996; Weber et al., 1997a; Roovers et al.,
Figure 6. Regulation of cyclin D1 and p21Cip/Waf protein. (A) Mor-
phology of pCEF/C3-transfected cells. (B) Cells were transfected
with a puromycin resistance vector combined with empty vector
(mock) or with a C3 toxin expression plasmid and selected for
transfectants in medium containing puromycin. Subsequently, the
cells were serum-starved, plated on polylysine or fibronectin, and
stimulated with growth factors 16 h later and lysed at the indicated
time points for Western blotting with antibodies against MAPK,
phospho-MAPK, or cyclin D1. (C) Untransfected cells (left) or
mock or pCEF/C3 transfected cells (right) were serum starved and
plated on the indicated substrates. 16 h later they were stimulated
with growth factors and lysed at the indicated time points for
Western blotting with antibodies against p21Cip/Waf. 
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1999). In addition, p21
 
Cip/Waf
 
 and p27
 
Kip1
 
 levels are sup-
pressed in adherent cells resulting in increased activity of
the cyclin E–cdk2 complex (Fang et al., 1996; Zhu et al.,
1996; Bottazzi et al., 1999). Integrin-mediated adhesion
regulates multiple growth factor–induced signal transduc-
tion cascades that are relevant to cell growth (Assoian,
1997; Howe et al., 1998). Fibronectin is particularly effi-
cient in promoting anchorage-dependent survival and pro-
liferation (Giancotti and Ruoslahti, 1999; Yamada and
Danen, 2000), and the fibronectin receptor, integrin 
 
a
 
5
 
b
 
1,
is required to propagate the mitogenic stimulus from fi-
bronectin into the cell (Varner et al., 1995; Davey et al.,
1999; Roovers et al., 1999). Here, we find that under serum-
free conditions, fibronectin is in fact unique in its support of
proliferation, due to its ability to stimulate the small GTPase
RhoA in addition to the Ras/MAPK cascade.
RhoA, Rac, and Cdc42 are all required for Ras-induced
transformation (Qiu et al., 1995a,b, 1997; Olson et al.,
1998), and microinjection of activated forms of any of
them can stimulate S phase entry (Olson et al., 1995).
RhoA activity is required in G1 progression for the degra-
dation of p27
 
Kip1
 
 and suppression of p21
 
Cip/Waf
 
 levels (Hirai
et al., 1997; Weber et al., 1997b; Adnane et al., 1998; Hu et
al., 1999), and RhoA counteracts the induction of p21
 
Cip/Waf
 
by oncogenic Ras (Olson et al., 1998). Rho family GTPases
can be activated by ECM as well as by growth factors
(Barry et al., 1997; Bourdoulous et al., 1998; Price et al.,
1998; Ren et al., 1999). In the present study, we find that
cell adhesion to fibronectin specifically stimulates the for-
mation of actin stress fibers and cell–matrix adhesions
(structures that are dependent on RhoA activity) in se-
rum-starved cells. Although several substrates stimulate
activation of MAPK and Rac, only fibronectin stimulates
activation of RhoA and supports G1 cell cycle progression
in a Rho-dependent manner. Our findings confirm and ex-
tend the notion that RhoA regulates p21Cip/Waf levels. It
has been previously reported that p21Cip/Waf is induced by
ERK activation and is suppressed later in G1 by cell at-
tachment through an unidentified mechanism (Bottazzi et
al., 1999). Our finding that trypsinization/replating tran-
siently activates ERK and induces p21Cip/Waf expression is
in agreement with this report. Moreover, we find that sub-
sequent suppression of p21Cip/Waf does not result from a
general effect of cell adhesion and spreading, but instead
requires the activation of RhoA, which is specifically stim-
ulated by fibronectin under serum-free conditions. Al-
though fibronectin only weakly suppresses transcription of
a p21Cip/Waf reporter, endogenous p21Cip/Waf RNA levels
are specifically and strongly suppressed in cells on fi-
bronectin, suggesting that p21Cip/Waf RNA degradation
may be enhanced in cells on fibronectin. Furthermore, the
difference in p21Cip/Waf protein levels in cells kept in sus-
pension or plated on polylysine suggests further regulation
at the protein level.
Our finding that the level of MAPK activation induced
by growth factor stimulation is reduced in cells kept in sus-
pension for 16 h is in agreement with a previous report
showing that the time of preincubation in suspension
(varying from 1 to 24 h) determines the effectiveness of
ERK activation (Renshaw et al., 1997). Stimulation of
MAPK by growth factors has previously been shown to be
supported by the interaction of various different integrins
with ECM components (Aplin et al., 1999). Our findings
are in agreement, except that in contrast to an earlier re-
port (Chen et al., 1994), we demonstrate in our system that
growth factors can activate MAPK even in cells plated on
the nonintegrin substrate polylysine. This may be related
to the fact that in our hands, cells plated on polylysine can
activate Rac1 and spread. The MAPK activation induced
by plating cells on fibronectin depends on integrity of the
actin cytoskeleton (Chen et al., 1994; Morino et al., 1995;
Zhu et al., 1995), whereas treatment with cytochalasin D
to disrupt actin filaments does not affect MAPK activation
by various types of soluble growth factors (Seufferlein et
al., 1996). In a later study, it was shown that low concen-
trations of cytochalasin D that disrupt actin stress fibers
and focal adhesions, but leave cortical actin structures in-
tact, permit efficient EGF signaling to ERK-type MAPKs
(Aplin and Juliano, 1999). Thus, our finding that cells
plated in the absence of serum on polylysine, laminin, or
collagen do show organization of actin in a cortical ring
may explain the efficient MAPK activation by growth fac-
tors that we observe in these cells.
ERK-type MAPKs are crucial for growth factor–
induced proliferation in fibroblasts (Pages et al., 1993),
and the capacity to induce a sustained pattern of MAPK
activation (over a 2-h period) has been correlated with the
mitogenic effects of growth factors (Kahan et al., 1992).
The activation of ERK-type MAPKs is followed by their
redistribution from the cytoplasm to the nucleus, where
they activate multiple transcription factors including Elk-1
(Treisman, 1996). In hamster embryonic fibroblasts, the
mitogenic effect of PDGF was found to depend on its abil-
ity to induce a sustained pattern of MAPK activation
(which can last up to 24 h), and this induction was linked to
the continued expression of cyclin D1 (Weber et al.,
1997a). It was later shown that integrin a5b1–mediated ad-
hesion could sustain the growth factor–induced MAPK re-
sponse in fibroblasts, resulting in the expression of cyclin
D1 (Roovers et al., 1999). Our data also show that the
MAPK response to growth factor stimulation is transient
in suspended cells but, in contrast to the results described
by Roovers et al., we find that in polylysine-attached cells,
growth factor stimulation can give rise to a sustained pat-
tern of MAPK activation and induce the translocation of
ERK into the nucleus. Thus, sustained activation and nu-
clear translocation of MAPK may be required, but is not
sufficient for G1 phase progression and S phase entry. Fur-
thermore, the regulation of a cyclin D1 luciferase reporter
is identical in suspended and attached cells and the accu-
mulation of endogenous cyclin D1 RNA is delayed but de-
tectable in suspended cells. Thus, cyclin D1 transcription
can occur under conditions where MAPK is only tran-
siently activated. However, accumulation of cyclin D1 pro-
tein occurs only in attached cells and its induction is most
efficient in cells plated on fibronectin. Thus, an important
level of regulation appears to be the accumulation of cyclin
D1 protein (either via control of translation or stability).
Finally, we show that Rho activity is involved in this regu-
latory mechanism since C3 inhibits cyclin D1 induction.
Active Cdc42 has been reported to enhance the MAPK
response to EGF in suspended cells, whereas active Rac1
or RhoA had no effect (Aplin and Juliano, 1999). In addi-
tion, constitutively activated Rac1 and Cdc42, but notDanen et al. Fibronectin Supports Proliferation via Rho and MAPK 1421
RhoA, can induce E2F transcriptional activity and anchor-
age-independent cyclin A induction (Gjoerup et al., 1998;
Philips et al., 2000). On the other hand, overexpression of
Cdc42 can inhibit proliferation via activation of p38
MAPK (Molnar et al., 1997), and disassembly of a fi-
bronectin matrix leading to decreased cyclin E–cdk2 activ-
ity was reported to be accompanied by increased Cdc42
and p38 MAPK activities and decreased RhoA activity
(Bourdoulous et al., 1998). We also find that in NIH-3T3
cells active Rac1 can stimulate S phase entry in suspended
cells or cells plated on polylysine whereas RhoA has no ef-
fect (not shown). However, the findings presented in this
study demonstrate that endogenous RhoA activity is re-
quired for G1 progression to occur and that integrin-medi-
ated adhesion to fibronectin stimulates this pathway. The
seemingly contradictory results seen with overexpression
of activated GTPases versus those seen with inhibition of
endogenous RhoA family members could be due to acti-
vation of endogenous RhoA by overexpression of acti-
vated Cdc42 or Rac1 (Mackay and Hall, 1998). Activity of
all three Rho family small GTPases appears to be re-
quired, and in cells expressing active RhoA, anchorage
may still be needed for the activation of Cdc42 and Rac1.
Moreover, whereas the stimulation of modest levels of
RhoA activity by matrix adhesion and growth factors is re-
quired, expression of too high levels of dominant-active
RhoA interferes with cell spreading and actually inhibits
cell cycle progression (not shown). Thus, the inhibition of
endogenous activity is probably a more accurate way to
evaluate the pathways involved than the expression of
high levels of activated forms of the small GTPases.
In conclusion, integrin-mediated cell adhesion to fi-
bronectin cooperates with growth factors to stimulate a
mitogenic signal transduction pathway (Fig. 7). Transient
MAPK activation by cell attachment or growth factors
results in the transcriptional activation of cyclin D1
and p21Cip/Waf genes. Cell spreading in general is associ-
ated with sustained MAPK activation and Rac1 activity,
whereas cell adhesion to fibronectin specifically activates
RhoA and suppresses p21Cip/Waf and induces cyclin D1
later in G1, in a Rho-dependent manner. Suppression of
p21Cip/Waf in fibronectin-adherent cells occurs through re-
duced RNA levels, whereas the specific induction of cyclin
D1 in cells plated on fibronectin occurs at the protein level
(through enhanced translation or protein stability). This fi-
bronectin-regulated mechanism is apparently subverted in
malignancy, where constitutively dysregulated signaling of
Ras/MAPK and Rho family GTPases can cooperate in on-
cogenic transformation.
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